Clinical Trial Update: Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating switching from a TDF-containing regimen to a TAF-containing fixed-dose combination in virologically suppressed HIV-1 patients; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TAF-containing fixed-dose combination
• TDF-containing regimen

Snippet

Sponsor: Gilead Sciences | Conditions: HIV, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2016-04-14